RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      루이소체 치매의 진단과 치료 = Diagnosis and Management of Dementia with Lewy Bodies

      한글로보기

      https://www.riss.kr/link?id=A99564730

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Dementia with Lewy bodies (DLB) is considered the second most common cause of neurodegenerative dementia. It is charac-terized with clinical and pathological feature that distinguish it from Alzheimer’s disease (AD). These characteristics include fl...

      Dementia with Lewy bodies (DLB) is considered the second most common cause of neurodegenerative dementia. It is charac-terized with clinical and pathological feature that distinguish it from Alzheimer’s disease (AD). These characteristics include fluc-tuating cognition, visual hallucination, and spontaneous feature of parkinsonism. DLB is commonly accompanied by neuropsy-chiatric symptoms and recent literature suggests that behavioral and psychological symptoms of dementia (BPDS) are frequently associated with DLB. So, psychiatrist caring for older adults may need a greater awareness of the clinical presentations of DLB in order to make a timely diagnosis. Also geriatric psychiatrist need to increase knowledge in order to raise awareness about the risks and benefits of medications in patients with DLB and to provide practical information and support for caregivers. This arti-cle reviews the clinical syndrome of DLB and its management.

      더보기

      목차 (Table of Contents)

      • 서론
      • 본론
      • 결론
      • REFERENCES
      • 서론
      • 본론
      • 결론
      • REFERENCES
      더보기

      참고문헌 (Reference)

      1 Molloy S, "The role of levodopa in the management of dementia with Lewy bodies" 76 : 1200-1203, 2005

      2 Hansen L, "The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity" 40 : 1-8, 1990

      3 Walker MP, "The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia" 177 : 252-256, 2000

      4 Collerton D, "Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia" 16 : 229-237, 2003

      5 Taki J, "Significance of 123IMIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease" 18 : 453-461, 2004

      6 Perry RH, "Senile dementia of Lewy body type and spectrum of Lewy body disease" 1 : 1088-, 1989

      7 Oka H, "Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease" 69 : 1460-1465, 2007

      8 Boeve BF, "REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies" 17 : 146-157, 2004

      9 Boeve BF, "REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease" 51 : 363-370, 1998

      10 Postuma RB, "Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder" 72 : 1296-1300, 2009

      1 Molloy S, "The role of levodopa in the management of dementia with Lewy bodies" 76 : 1200-1203, 2005

      2 Hansen L, "The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity" 40 : 1-8, 1990

      3 Walker MP, "The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia" 177 : 252-256, 2000

      4 Collerton D, "Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia" 16 : 229-237, 2003

      5 Taki J, "Significance of 123IMIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease" 18 : 453-461, 2004

      6 Perry RH, "Senile dementia of Lewy body type and spectrum of Lewy body disease" 1 : 1088-, 1989

      7 Oka H, "Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease" 69 : 1460-1465, 2007

      8 Boeve BF, "REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies" 17 : 146-157, 2004

      9 Boeve BF, "REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease" 51 : 363-370, 1998

      10 Postuma RB, "Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder" 72 : 1296-1300, 2009

      11 O’Brien JT, "Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia" 56 : 1386-1388, 2001

      12 Kosaka K, "Presenile dementia with Alzheimer-, Pick- and Lewy-body changes" 36 : 221-233, 1976

      13 Duda JE, "Pathology and neurotransmitter abnormalities of dementia with Lewy bodies" 17 (17): 3-14, 2004

      14 McKeith IG, "Operational criteria for senile dementia of Lewy body type (SDLT)" 22 : 911-922, 1992

      15 Lobotesis K, "Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD" 56 : 643-649, 2001

      16 Imamura T, "Occipital glucose metabolism in dementia with lewy bodies with and without Parkinsonism: a study using positron emission tomography" 12 : 194-197, 2001

      17 McKeith I, "Neuroleptic sensitivity in patients with senile dementia of Lewy body type" 305 : 673-678, 1992

      18 Aarsland D, "Neuroleptic sensitivity in Parkinson’s disease and parkinsonian dementias" 66 : 633-637, 2005

      19 Emre M, "Memantine for patients with Parkinson’s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo- controlled trial" 9 : 969-977, 2010

      20 Boeve BF, "Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients" 4 : 281-284, 2003

      21 Hashimoto M, "Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study" 51 : 357-362, 1998

      22 Hansen LA, "Lewy body disease" 5 : 889-894, 1992

      23 Galvin JE, "Lewy body dementia: the caregiver experience of clinical care" 16 : 388-392, 2010

      24 Galvin JE, "Lewy body dementia: caregiver burden and unmet needs" 24 : 177-181, 2010

      25 Kosaka K, "Lewy bodies in cerebral cortex, report of three cases" 42 : 127-134, 1978

      26 Lucetti C, "Levodopa response in dementia with lewy bodies: a 1-year followup study" 16 : 522-526, 2010

      27 Bonelli SB, "L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia" 63 : 376-378, 2004

      28 Graff-Radford J, "Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies" 135 (135): 2470-2477, 2012

      29 Arnulf I, "Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis" 55 : 281-288, 2000

      30 Holdorff B., "Friedrich Heinrich Lewy (1885-1950) and his work" 11 : 19-28, 2002

      31 Imamura T, "Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer’s disease" 7 : 77-79, 2000

      32 Burn DJ, "Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study" 18 : 884-889, 2003

      33 McKeith I, "Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study" 356 : 2031-2036, 2000

      34 Edwards K, "Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study" 23 : 401-405, 2007

      35 Briel RC, "EEG findings in dementia with Lewy bodies and Alzheimer’s disease" 66 : 401-403, 1999

      36 Mori E, "Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial" 72 : 41-52, 2012

      37 Kosaka K, "Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease" 3 : 185-192, 1984

      38 Okazaki H, "Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion" 20 : 237-244, 1961

      39 Lennox G, "Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry" 52 : 1236-1247, 1989

      40 Lennox G, "Diffuse Lewy body disease" 1 : 323-324, 1989

      41 Walker Z, "Differentiation of dementia with Lewy bodies from Alzheimer’s disease using a dopaminergic presynaptic ligand" 73 : 134-140, 2002

      42 McKeith IG, "Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium" 65 : 1863-1872, 2005

      43 Omerovic M, "Dementia with Lewy bodies. Clinical improvement under treatment with an acetylcholinesterase inhibitor" 78 : 1052-1057, 2007

      44 Bradley BF, "Dementia with Lewy bodies" 10 : 81-112, 2004

      45 McKeith I, "Dementia with Lewy bodies" 3 : 19-28, 2004

      46 Byrne EJ, "Dementia and Parkinson’s disease associated with diffuse cortical Lewy bodies" 1 : 501-, 1987

      47 Ferman TJ, "DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging" 62 : 181-187, 2004

      48 Mori T, "Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB" 66 : 935-937, 2006

      49 Galasko DR, "Continnum Lifelong Learning" 13 : 69-86, 2007

      50 McKeith IG, "Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop" 47 : 1113-1124, 1996

      51 Ricci M, "Clinical findings, functional abilities and caregiver distress in the early stage of dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD)" 49 : e101-e104, 2009

      52 Gibb WR, "Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia)" 110 (110): 1131-1153, 1987

      53 Schenck CH, "Chronic behavioral disorders of human REM sleep: a new category of parasomnia" 9 : 293-308, 1986

      54 Orimo S, "Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease" 109 : 583-588, 2005

      55 Donnemiller E, "Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease" 24 : 320-325, 1997

      56 Swanberg MM, "Benefit-risk considerations in the treatment of dementia with Lewy bodies" 25 : 511-523, 2002

      57 Borroni B, "Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment" 46 : 101-106, 2008

      58 Cousins DA, "Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease: an MRI study" 61 : 1191-1195, 2003

      59 Zaccai J, "A systematic review of prevalence and incidence studies of dementia with Lewy bodies" 34 : 561-566, 2005

      60 Barber R, "A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer’s disease: magnetic resonance imaging volumetric study" 12 : 198-205, 2001

      61 Yoshita M, "A clinical role for [(123)I] MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer’s-type and dementia with Lewy bodies" 71 : 583-588, 2001

      62 Whitworth HB, "A caregiver’s guide to Lewy body dementia" Demoshealth 37-40, 2011

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-02-22 학술지명변경 외국어명 : Journal of Korean Geriatirc Psychiatry -> Journal of Korean Geriatric Psychiatry KCI등재
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2013-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2012-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2010-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.19 0.19 0.22
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.31 0.28 0.593 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼